Extraocular muscle palsy from metastatic prostate cancer

Autor: Brian P. Monahan, Minocher Battiwalla, Jean L. Grem, John B Stockle, Gregory D. Leonard, Robert A Harris
Rok vydání: 2003
Předmět:
Zdroj: The Lancet. Oncology. 4(6)
ISSN: 1470-2045
Popis: THE LANCET Oncology Vol 4 June 2003 http://oncology.thelancet.com 358 68 Paz MF, Fraga MF, Avila S, et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 2003; 63: 1114–21. 69 Wijermans PW, Krulder JW, Huijgens PC, et al. Continuous infusion of low-dose 5-Aza-2’-deoxycytidine in elderly patients with high-risk myelodysplastic syndrome. Leukemia 1997; 11: 1–5. 70 Schwartsmann G, Fernandes MS, Schaan MD, et al. Decitabine (5-Aza-2’-deoxycytidine; DAC) plus daunorubicin as a first line treatment in patients with acute myeloid leukemia: preliminary observations. Leukemia 1997; 11 (suppl): S28–31. 71 Wijermans P, Lubbert M, Verhoef G, et al. Low-dose 5-aza-2’deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients. J Clin Oncol 2000; 18: 956–62. 72 Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the reexpression of genes silenced in cancer. Nat Genet 1999; 21: 103–07. 73 Ballestar E, Esteller M. The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 2002; 23: 1103–09. 74 Daskalakis M, Nguyen TT, Nguyen C, et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2’-deoxycytidine (decitabine) treatment. Blood 2002; 100: 2957–64. 75 Lo Coco F, Zelent A, Kimchi A, et al. Progress in differentiation induction as a treatment for acute promyelocytic leukemia and beyond. Cancer Res 2002; 62: 5618–21. 76 Soengas MS, Capodieci P, Polsky D, et al. Inactivation of the apoptosis effector Apaf-1 in melanoma. Nature 2001; 409: 207–11. Review DNA methylation
Databáze: OpenAIRE